Original language | English |
---|---|
Pages (from-to) | e239-e242 |
Journal | International Journal of Laboratory Hematology |
Volume | 44 |
Issue number | 5 |
DOIs | |
State | Published - Oct 2022 |
Bibliographical note
Funding Information:Janssen Pharmaceuticals, Grant/Award Number: Oncology Grant; United States‐Israel Binational Science Foundation, Grant/Award Number: 20130432; Bar‐Ilan University Funding information
Funding Information:
This study was supported by Janssen Oncology Grant (to Meirav Kedmi) and by the US‐Israel Binational Science Foundation (BSF) grant number 20130432 (to Ramit Mehr). Hadas Neuman was supported by a Bar‐Ilan University President's Scholarship.
Funding
Janssen Pharmaceuticals, Grant/Award Number: Oncology Grant; United States‐Israel Binational Science Foundation, Grant/Award Number: 20130432; Bar‐Ilan University Funding information This study was supported by Janssen Oncology Grant (to Meirav Kedmi) and by the US‐Israel Binational Science Foundation (BSF) grant number 20130432 (to Ramit Mehr). Hadas Neuman was supported by a Bar‐Ilan University President's Scholarship.
Funders | Funder number |
---|---|
Janssen Oncology | |
Janssen Pharmaceuticals | |
United States-Israel Binational Science Foundation | 20130432 |